Wells Fargo & Company Nova Bay Pharmaceuticals, Inc. Put Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NBY
# of Institutions
1Shares Held
2.94KCall Options Held
0Put Options Held
0About NovaBay Pharmaceuticals, Inc.
- Ticker NBY
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,988,400
- Market Cap $45.5M
- Description
- NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...